Evidence map›Paper›PMID 25823732›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Reply to B. O'Sullivan et Al.

Carole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tan, David Rosenthal, Adel K El-Naggar, Adam S Garden, Denis Soulieres, Andy Trotti, Vilija N Avizonis, John A Ridge and 3 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Carole FakhryJohns Hopkins Medical Institutions, Baltimore, MD cfakhry@jhmi.edu.
Qiang ZhangRadiation Therapy Oncology Group Statistical Center, Philadelphia, PA.
Phuc Felix Nguyen-TanCente Hospitalier de l'Université de Montréal Hospital Notre Dame, Montreal, Quebec, Canada.
David RosenthalUniversity of Texas MD Anderson Cancer Center, Houston, TX.
Adel K El-NaggarUniversity of Texas MD Anderson Cancer Center, Houston, TX.
Adam S GardenUniversity of Texas MD Anderson Cancer Center, Houston, TX.
Denis SoulieresCente Hospitalier de l'Université de Montréal Hospital Notre Dame, Montreal, Quebec, Canada.
Andy TrottiH. Lee Moffitt Cancer Center, Tampa, FL.
Vilija N AvizonisIntermountain Medical Center, Murray, UT.
John A RidgeFox Chase Cancer Center, Philadelphia, PA.
Jonathan HarrisRadiation Therapy Oncology Group Statistical Center, Philadelphia, PA.
Quynh-Thu LeStanford University Medical Center, Stanford, CA.
Maura GillisonOhio State University Medical Center, Columbus, OH.

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
Statistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mei-Yin C Polley · 2014 to 2026
$146.4M
NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Squamous CellFemaleHumansMaleNeoplasm ProteinsOropharyngeal NeoplasmsPapillomaviridaeNeoplasm Proteins

Identifiers

PMID25823732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.